The Valley Desk

NCT01451541 · Interventional trial

A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).

Overall registry status Completed

Phase 3

Conditions PAR, Perennial Allergic Rhinitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov